Liwei Zhao

4.1k total citations · 1 hit paper
74 papers, 2.0k citations indexed

About

Liwei Zhao is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Liwei Zhao has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 22 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Liwei Zhao's work include Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Autophagy in Disease and Therapy (10 papers). Liwei Zhao is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Autophagy in Disease and Therapy (10 papers). Liwei Zhao collaborates with scholars based in China, France and Sweden. Liwei Zhao's co-authors include Peng Liu, Oliver Kepp, Guido Kroemer, Takahiro Yamazaki, Jitka Fučíková, Lorenzo Galluzzi, Lenka Kašíková, Giulia Petroni, Radek Špíšek and Laurence Zitvogel and has published in prestigious journals such as The EMBO Journal, Molecular Cell and Bioresource Technology.

In The Last Decade

Liwei Zhao

69 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of immunogenic cell death and its relevance for cancer therapy

2020 756 citations Oliver Kepp, Peng Liu et al. Cell Death and Disease profile →

Peers

Liwei Zhao

IMMUN

ONCOL

PRM

Yoriko Yamashita Japan

Jong‐Ho Cha South Korea

Xiaoyu Yin China

Aimin Meng China

Ning Guo China

Shengyu Yang United States

Qing Chang China

Juan F. Santibáñez Serbia

Krzysztof T. Drzewiecki Denmark

Yoriko Yamashita Japan

Liwei Zhao

351 ×0.5

IMMUN

545 ×0.9

ONCOL

567 ×1.0

198 ×0.5

468 ×1.5

PRM

Citations per year, relative to Liwei Zhao Liwei Zhao (= 1×) peers Yoriko Yamashita

Countries citing papers authored by Liwei Zhao

Since Specialization

Citations

This map shows the geographic impact of Liwei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Zhao more than expected).

Fields of papers citing papers by Liwei Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Zhao. The network helps show where Liwei Zhao may publish in the future.

Co-authorship network of co-authors of Liwei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei Zhao. A scholar is included among the top collaborators of Liwei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei Zhao. Liwei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Liwei, et al.. (2025). Thermal simulation and experimental study on TiCN/Ni60 cladding coating assisted by electromagnetic. Thermal Science and Engineering Progress. 59. 103242–103242. 5 indexed citations

Forveille, Sabrina, Liwei Zhao, Allan Sauvat, et al.. (2025). Patritumab deruxtecan induces immunogenic cell death. OncoImmunology. 14(1). 2514050–2514050. 4 indexed citations

Zhao, Liwei, Peng Liu, Oliver Kepp, & Guido Kroemer. (2025). Mitochondrial DNA transfer between malignant cells and T lymphocytes shapes the cancer-immunity dialogue. OncoImmunology. 14(1). 2512109–2512109. 1 indexed citations

Liu, Fengjiao, Yunlong Jia, Liwei Zhao, et al.. (2024). Escin ameliorates CUMS-induced depressive-like behavior via BDNF/TrkB/CREB and TLR4/MyD88/NF-κB signaling pathways in rats. European Journal of Pharmacology. 984. 177063–177063. 9 indexed citations

Wang, Guixin, et al.. (2024). Integrating Bulk and Single-cell RNA-seq to Construct a Macrophage-related Prognostic Model for Prognostic Stratification in Triple-negative Breast Cancer. Journal of Cancer. 15(18). 6002–6015. 6 indexed citations

Wang, Zhao, Liwei Zhao, Xiaojuan Li, et al.. (2024). Environmental Dyeing and Functionalization of Silk Fabrics with Natural Dye Extracted from Lac. Molecules. 29(10). 2358–2358. 8 indexed citations

Liu, Peng, Liwei Zhao, Laurence Zitvogel, Oliver Kepp, & Guido Kroemer. (2023). The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation. Cell Death and Differentiation. 30(12). 2447–2451. 8 indexed citations

Naour, Julie Le, Sylvain Thierry, Sarah Adriana Scuderi, et al.. (2023). A Chemically Defined TLR3 Agonist with Anticancer Activity. OncoImmunology. 12(1). 2227510–2227510. 7 indexed citations

Zhang, Shuai, Liwei Zhao, Mengfei Guo, et al.. (2023). Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses. Journal for ImmunoTherapy of Cancer. 11(7). e006785–e006785. 11 indexed citations

10.

Forveille, Sabrina, Allan Sauvat, Shuai Zhang, et al.. (2022). Assessment of type I interferon responses as a feature of immunogenic cell death. Methods in cell biology. 172. 135–143. 4 indexed citations

11.

Zhao, Liwei, Peng Liu, Wei Xie, et al.. (2021). A genotype-phenotype screening system using conditionally immortalized immature dendritic cells. STAR Protocols. 2(3). 100732–100732. 12 indexed citations

12.

Tian, Ai-Ling, Qi Wu, Peng Liu, et al.. (2021). Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response. Cell Death and Disease. 12(1). 6–6. 27 indexed citations

13.

Liu, Peng, Liwei Zhao, Gladys Ferrere, et al.. (2020). Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. OncoImmunology. 9(1). 1789284–1789284. 4 indexed citations

14.

Kepp, Oliver, Peng Liu, Liwei Zhao, Isabelle Plo, & Guido Kroemer. (2020). Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis. OncoImmunology. 9(1). 1792037–1792037. 16 indexed citations

15.

Cerrato, Giulia, Marion Leduc, Kévin Müller, et al.. (2020). Oleate-induced aggregation of LC3 at the trans-Golgi network is linked to a protein trafficking blockade. Cell Death and Differentiation. 28(5). 1733–1752. 8 indexed citations

16.

Kepp, Oliver, Allan Sauvat, Marion Leduc, et al.. (2019). A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers. OncoImmunology. 8(8). 1606665–1606665. 14 indexed citations

17.

Liu, Peng, Liwei Zhao, Oliver Kepp, & Guido Kroemer. (2019). Quantitation of calreticulin exposure associated with immunogenic cell death. Methods in enzymology on CD-ROM/Methods in enzymology. 632. 1–13. 23 indexed citations

18.

Liu, Peng, Liwei Zhao, Friedemann Loos, et al.. (2019). Immunosuppression by Mutated Calreticulin Released from Malignant Cells. Molecular Cell. 77(4). 748–760.e9. 73 indexed citations

19.

Zhou, Heng, Laura Mondragón, Wei Xie, et al.. (2018). Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals. Cell Death and Disease. 9(11). 1086–1086. 17 indexed citations

20.

Zhao, Liwei, Peng Liu, Guang‐Qin Guo, & Li Wang. (2012). Combination of cytokinin and auxin induces apoptosis, cell cycle progression arrest and blockage of the Akt pathway in HeLa cells. Molecular Medicine Reports. 12(1). 719–727. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact